Simlot T F Tablets
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Youn Life Science Co., Ltd.
MFDS item code 202002852 · Approved 2020.04.22
This product's status changed to Approval withdrawn on 2025.02.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
This medication is used to lower elevated total cholesterol, LDL cholesterol, Apo B protein, and triglycerides, while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia. In patients with homozygous familial hypercholesterolemia, it may be used as an adjunct to other lipid-lowering treatments or alone when alternative therapies are not feasible. This medication is particularly recommended when diet or non-drug treatments do not adequately respond, and its effectiveness is maximized when used together with appropriate dietary regimens. It is important to identify and manage underlying secondary causes, such as diabetes or hypothyroidism, before treatment. Accurate measurement of lipid levels helps in formulating a treatment plan tailored to the patient's condition. In conclusion, this medication is effectively used to reduce the risk of hypercholesterolemia and associated cardiovascular diseases.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start with 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, administration of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with abnormal liver function under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and monitor closely when administering higher doses of this medicine to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.
This medication can cause serious muscle-related side effects, such as myopathy and rhabdomyolysis. If you experience muscle pain or weakness, you should immediately inform your doctor, who can check for muscle damage through blood tests. The risk of muscle side effects increases, especially at high doses, so caution is needed. This medication should not be used in patients with severe liver disease, pregnant women, or nursing mothers. It should also not be taken by individuals with known hypersensitivity to this medication. The risk of muscle side effects may increase when used in combination with other specific medications, so you must inform your doctor or pharmacist of any other drugs you are taking. Elderly patients or those with muscle weakness should use this medication with extra caution and regular health check-ups are necessary. Due to potential impacts on liver function, it is recommended to undergo regular liver function tests. Women of childbearing potential should confirm their pregnancy status before taking this medication, and it should be discontinued during pregnancy. Nursing mothers should also stop breastfeeding if taking this medication, as it may affect the infant. While taking this medication, unexplained muscle pain, weakness, fatigue, or gastrointestinal symptoms may occur, so consult a healthcare professional immediately if any such symptoms arise. Lastly, it is important to regularly monitor liver function and muscle condition through blood tests during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It should be kept at room temperature between 1°C and 30°C, away from excessively hot or cold places.
White to off-white, biconvex, rectangular tablet
30 tablets/PTP[(10 tablets/PTP ×3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Youn Life Science Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.